The advantage of focusing on these two tumor types is that MEC has a single molecular abnormality, t(11;19), resulting in rearrangement of the MAML2 gene, which is thought to be specific for MEC34, unlike many other gene fusions and mutations. Here, MAML2 is linked to mucoepidermoid carcinoma.